Diabetes Moves Down the List of Priorities for Big Pharma

Bookmark
(Bloomberg) -- While Sanofi and other Big Pharma companies rush toward cutting-edge therapies that unleash the immune system to fight cancer or potentially cure DNA flaws, diabetes is moving down t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.